Internal Medicine, Medical Oncology · Sebring, FL
NPI
1700880697
Since 2005
Specialty
Internal Medicine, Medical Oncology
Code 207RX0202X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
1396 Whisper Cir
Sebring, FL, 33870
Phone (863) 385-1244
Groups this clinician bills Medicare through
Medicare paid, 2024
$4.5M
319,414 services
Medicare patients, 2024
1,217
Average age 77
Drug cost, 2024
$5.5M
1,694 prescriptions
Company payments, 2025
$6,793
From 48 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Syed E Ahmed was code Q0138 (injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use)), 49,980 times for 56 patients. In total Syed E Ahmed billed 319,414 services in 166 codes, and Medicare paid $4.5M.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2026-03-24.
| Code | Setting | Services | Patients | Paid per service | Medicare paid |
|---|
| Q0138 Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) | Office | 49,980 | 56 | $0.28 | $14K |
| J1756 Injection, iron sucrose, 1 mg | Office | 24,300 | 43 | $0.18 | $4,292 |
| J0897 Injection, denosumab, 1 mg | Office | 16,800 | 104 | $20.64 | $347K |
| J9271 Injection, pembrolizumab, 1 mg | Office | 11,800 | 19 | $44.64 | $527K |
| J0885 Injection, epoetin alfa, (for non-esrd use), 1000 units | Office | 10,190 | 49 | $6.34 | $65K |
| J0185 Injection, aprepitant, 1 mg | Office | 6,370 | 14 | $1.34 | $8,532 |
| J1569 Injection, immune globulin, (gammagard liquid), non-lyophilized, (e.g., liquid), 500 mg | Office | 4,394 | 16 | $35.73 | $157K |
| 85025 Blood Count | Office | 2,379 | 780 | $7.61 | $18K |
| 36415 Venipuncture Blood Collection | Office | 2,343 | 801 | $8.65 | $20K |
| J1100 Injection, dexamethasone sodium phosphate, 1 mg | Office | 2,058 | 57 | $0.09 | $186 |
| 99214 Office E&M - Established | Office | 1,560 | 627 | $94.18 | $147K |
| 96372 Injection Administration | Office | 1,450 | 326 | $10.40 | $15K |
| J2469 Injection, palonosetron hcl, 25 mcg | Office | 1,210 | 33 | $0.72 | $874 |
| J3420 Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | Office | 612 | 132 | $0.96 | $587 |
| 96375 Injection Administration | Office | 589 | 85 | $11.44 | $6,737 |
By year: 2022 $4.7M for 333,143 services; 2023 $4.4M for 321,462 services; 2024 $4.5M for 319,414 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 85025 Blood Count | 2,379 | 780 | $7.61 | $18K |
| 36415 Venipuncture Blood Collection | 2,343 | 801 | $8.65 | $20K |
| 85046 Blood Count | 63 | 63 | $5.46 | $344 |
| 81003 Clinical Chemistry | 38 | 19 | $2.20 | $83.6 |
| 85045 Blood Count | 20 | 20 | $3.91 | $78.2 |
Medicare prescription drug claims, 2024
In 2024, the drug Syed E Ahmed prescribed most often to Medicare patients was Anastrozole, with 139 prescriptions and refills. In total Syed E Ahmed wrote 1,694 Medicare prescriptions that cost $5.5M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Anastrozole Generic | 139 | 358 | 47 | $2,907 |
| Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen | 117 | 117 | 40 | $9,731 |
| Dexamethasone Generic | 86 | 116 | 35 | $1,754 |
| Hydroxyurea Generic | 72 | 165 | 21 | $2,157 |
| Ondansetron Odt Ondansetron | 65 | 67 | 46 | $1,405 |
| Pantoprazole Sodium Generic | 64 | 107 | 25 | $445 |
| Prednisone Generic | 58 | 69 | 30 | $277 |
| Acyclovir Generic | 55 | 80 | 15 | $339 |
| Revlimid Lenalidomide | 53 | 53 | Under 11 | $884K |
| Abiraterone Acetate Generic | 45 | 45 | Under 11 | $24K |
| Oxycodone Hcl Generic | 41 | 41 | 16 | $851 |
| Gabapentin Generic | 40 | 54 | 14 | $485 |
| Prochlorperazine Maleate Generic | 39 | 41 | 32 | $943 |
| Lorazepam Generic | 36 | 36 | 21 | $119 |
| Tramadol Hcl Generic | 33 | 36 | 15 | $292 |
Brand drugs: 402 claims; generic drugs: 1,292 claims; opioid claims: 224.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Syed E Ahmed $6,793 ($6,793 in general payments such as food, travel and fees) from 48 companies. The largest payer was Janssen Biotech, Inc. with $946.
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. JNJ | 36 | $946 |
| AstraZeneca Pharmaceuticals LP AZN | 30 | $759 |
| Pfizer Inc. PFE | 28 | $448 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 19 | $428 |
| Celgene Corporation BMY | 13 | $346 |
| Merck Sharp & Dohme LLC MRK | 14 | $324 |
| Novartis Pharmaceuticals Corporation NVS | 18 | $290 |
| Seagen Inc. PFE | 3 | $275 |
| Incyte Corporation INCY | 6 | $224 |
| Genzyme Corporation SNY | 10 | $183 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.